Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 70

Cited In for PubMed (Select 7874169)

1.

Closing the Gap: Genetic and Genomic Continuum from Syndromic to Nonsyndromic Craniosynostoses.

Heuzé Y, Holmes G, Peter I, Richtsmeier JT, Jabs EW.

Curr Genet Med Rep. 2014 Sep 1;2(3):135-145.

3.

The Fibroblast Growth Factor signaling pathway.

Ornitz DM, Itoh N.

Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66. doi: 10.1002/wdev.176. Epub 2015 Mar 13.

4.

FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.

Karolak MR, Yang X, Elefteriou F.

Hum Mol Genet. 2015 May 1;24(9):2552-64. doi: 10.1093/hmg/ddv019. Epub 2015 Jan 23.

PMID:
25616962
5.

Pfeiffer syndrome: clinical and genetic findings in five Brazilian families.

Júnior HM, de Aquino SN, Machado RA, Leão LL, Coletta RD, Burle-Aguiar MJ.

Med Oral Patol Oral Cir Bucal. 2015 Jan 1;20(1):e52-8.

6.

Mutational identification of fibroblast growth factor receptor 1 and fibroblast growth factor receptor 2 genes in craniosynostosis in Indian population.

Pandey RK, Bajpai M, Ali A, Gayan S, Singh A.

Indian J Hum Genet. 2013 Oct;19(4):449-53. doi: 10.4103/0971-6866.124374.

7.

Molecular Analysis of Twist1 and FGF Receptors in a Rabbit Model of Craniosynostosis: Likely Exclusion as the Loci of Origin.

Gallo PH, Cray JJ Jr, Durham EL, Mooney MP, Cooper GM, Kathju S.

Int J Genomics. 2013;2013:305971. doi: 10.1155/2013/305971. Epub 2013 May 8.

8.

Syndromic craniosynostosis.

Derderian C, Seaward J.

Semin Plast Surg. 2012 May;26(2):64-75. doi: 10.1055/s-0032-1320064.

9.

The ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.

Ono K, Karolak MR, Ndong Jde L, Wang W, Yang X, Elefteriou F.

Hum Mol Genet. 2013 Aug 1;22(15):3048-62. doi: 10.1093/hmg/ddt162. Epub 2013 Apr 9.

10.

The fibroblast growth factor receptor 2 p.Ala172Phe mutation in Pfeiffer syndrome--history repeating itself.

Jay S, Wiberg A, Swan M, Lester T, Williams LJ, Taylor IB, Johnson D, Wilkie AO.

Am J Med Genet A. 2013 May;161A(5):1158-63. doi: 10.1002/ajmg.a.35842. Epub 2013 Mar 26.

11.

The genetic basis of female reproductive disorders: etiology and clinical testing.

Layman LC.

Mol Cell Endocrinol. 2013 May 6;370(1-2):138-48. doi: 10.1016/j.mce.2013.02.016. Epub 2013 Mar 14. Review.

12.

Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism.

Agochukwu NB, Solomon BD, Benson LJ, Muenke M.

Am J Med Genet A. 2013 Mar;161A(3):453-60. doi: 10.1002/ajmg.a.35233. Epub 2013 Feb 1. Review.

13.

Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient mice.

McGee-Lawrence ME, Li X, Bledsoe KL, Wu H, Hawse JR, Subramaniam M, Razidlo DF, Stensgard BA, Stein GS, van Wijnen AJ, Lian JB, Hsu W, Westendorf JJ.

J Biol Chem. 2013 Feb 22;288(8):5291-302. doi: 10.1074/jbc.M112.414995. Epub 2013 Jan 7.

14.

Craniosynostosis: molecular pathways and future pharmacologic therapy.

Senarath-Yapa K, Chung MT, McArdle A, Wong VW, Quarto N, Longaker MT, Wan DC.

Organogenesis. 2012 Oct-Dec;8(4):103-13. doi: 10.4161/org.23307. Epub 2012 Oct 1. Review.

15.

Craniofacial surgery, from past pioneers to future promise.

Wan DC, Kwan MD, Kumar A, Bradley JP, Longaker MT.

J Maxillofac Oral Surg. 2009 Dec;8(4):348-56. doi: 10.1007/s12663-009-0084-x. Epub 2010 Apr 24.

16.

Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.

Agochukwu NB, Solomon BD, Muenke M.

Childs Nerv Syst. 2012 Sep;28(9):1447-63. doi: 10.1007/s00381-012-1756-2. Epub 2012 Aug 8. Review.

17.

The epidemiology, genetics and future management of syndactyly.

Jordan D, Hindocha S, Dhital M, Saleh M, Khan W.

Open Orthop J. 2012;6:14-27. doi: 10.2174/1874325001206010014. Epub 2012 Mar 23.

18.

Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction.

Miraoui H, Dwyer A, Pitteloud N.

Mol Cell Endocrinol. 2011 Oct 22;346(1-2):37-43. doi: 10.1016/j.mce.2011.05.042. Epub 2011 Jun 1. Review.

19.

Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling.

Guntur AR, Reinhold MI, Cuellar J Jr, Naski MC.

Development. 2011 Apr;138(7):1433-44. doi: 10.1242/dev.058016.

20.

Targeting mutant fibroblast growth factor receptors in cancer.

Greulich H, Pollock PM.

Trends Mol Med. 2011 May;17(5):283-92. doi: 10.1016/j.molmed.2011.01.012. Epub 2011 Mar 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk